Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Quintiles' NovaQuest unit received rights to market PSK's Sancuso granisetron patch
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury